Are you Dr. Trevarthen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Summary
- Dr. David Trevarthen, MD is an oncologist in Spokane, Washington. He is currently licensed to practice medicine in Washington, Kansas, and Wyoming. He is affiliated with AdventHealth Porter, Swedish Medical Center, and St Anthony North Medical Pavilion.
Education & Training
- Saint Joseph HospitalResidency, Internal Medicine, 1974 - 1977
- University of Wisconsin School of Medicine & Public HealthClass of 1974
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CO State Medical License 1975 - 2025
- KS State Medical License 2023 - 2025
- WY State Medical License 2022 - 2025
- WA State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 15 citationsEfficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.Panayiotis Panayiotidis, George A Follows, Luigina Mollica, Arnon Nagler, Muhit Ozcan
Blood Advances. 2021-02-09 - 97 citationsLong‐term safety and efficacy of the PI3K‐ inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 studyMartin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George A Follows
American Journal of Hematology. 2020-04-01 - 62 citationsAnalysis of cell-free DNA from 32,989 advanced cancers reveals novel co-occurring activating RET alterations and oncogenic signaling pathway aberrationsThereasa A. Rich, Karen L. Reckamp, Young Kwang Chae, Robert C. Doebele, Wade T. Iams
Clinical Cancer Research. 2019-01-01
Professional Memberships
- Member
- Member